Bonnie Tackett
Family Medicine · Atchison, KSNPI 1346688405
Payments from drug & device makers
Across 145 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$530
- Lilly USA, LLC$198
- Pfizer$188
- Amgen$138
- Astellas Pharma US Inc$118
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$97
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,317100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $530 |
| Lilly USA, LLC | 13 | $198 |
| Pfizer | 13 | $188 |
| Amgen | 10 | $138 |
| Astellas Pharma US Inc | 7 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $97 |
| Abbott | 4 | $90 |
| AstraZeneca | 7 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| GSK | 5 | $71 |
| Boehringer Ingelheim | 4 | $68 |
| Sanofi-aventis U.S. LLC | 5 | $62 |
| Johnson & Johnson | 4 | $52 |
| Novo Nordisk | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 1 | $50 |
| Amarin Pharma, Inc. | 3 | $48 |
| Cequr Corporation | 1 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Eisai Inc. | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Novartis | 2 | $28 |
| Sanofi Pasteur Inc. | 2 | $28 |
| Merck | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
| CSL Behring | 1 | $4 |
How this compares
$2,321 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 42 | $46,923 |
| JardianceEmpagliflozin | 44 | $42,828 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 13 | $30,153 |
| JanuviaSitagliptin Phosphate | 24 | $20,509 |
| MounjaroTirzepatide | 19 | $19,286 |
| EliquisApixaban | 23 | $15,717 |
| MovantikNaloxegol Oxalate | 17 | $10,354 |
| Spiriva HandihalerTiotropium Bromide | 15 | $9,634 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,245 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,457 |
| FarxigaDapagliflozin Propanediol | 11 | $6,096 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,630 |
| Incruse ElliptaUmeclidinium Bromide | 15 | $5,594 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $5,207 |
| Lidocaine | 13 | $4,485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $50 | $46,92342 claims |
| Boehringer IngelheimJardiance | $68 | $42,82844 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Shingrix | $71 | $29,29667 claims |
| MerckJanuvia, Dulera | $26 | $23,25035 claims |
| Lilly USA, LLCMounjaro | $198 | $19,28619 claims |
| PfizerEliquis | $188 | $15,71723 claims |
| AstraZenecaFarxiga, Symbicort | $90 | $9,62426 claims |
| AbbVieSavella | $530 | $2,79312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Atchison
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.